Sandoz Group AG
SDZNY · OTC
Bulios Fair Price
$43.12
48.4% downside
Current Price
$83.62
According to Bulios Fair Price, SDZNY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Sandoz Group AG is a Swiss pharmaceutical company specializing in the production of generic drugs and biosimilar products. Founded in 1886, it is now a part of the Novartis group. Sandoz is one of the global leaders in generics, producing drugs that are identical to original products but more affordable. The company focuses on areas such as oncology, cardiovascular diseases, neurology, and infections. Sandoz is known for its innovation in biotechnology, providing high-quality, safe, and affordable treatments to patients worldwide.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard Saynor
Employees
23,000
Headquarters
Basel